nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.421	0.5	CpDpCtD
Fludrocortisone—Parkinson's disease—Memantine—Alzheimer's disease	0.421	0.5	CpDpCtD
Fludrocortisone—Cutaneous hypersensitivity—Rivastigmine—Alzheimer's disease	0.00434	0.0368	CcSEcCtD
Fludrocortisone—Skin striae—Donepezil—Alzheimer's disease	0.00375	0.0318	CcSEcCtD
Fludrocortisone—Cardiomegaly—Donepezil—Alzheimer's disease	0.00327	0.0277	CcSEcCtD
Fludrocortisone—Cardiomegaly—Memantine—Alzheimer's disease	0.00297	0.0251	CcSEcCtD
Fludrocortisone—Trauma—Rivastigmine—Alzheimer's disease	0.00222	0.0189	CcSEcCtD
Fludrocortisone—Osteoporosis—Donepezil—Alzheimer's disease	0.00213	0.018	CcSEcCtD
Fludrocortisone—Hypernatraemia—Memantine—Alzheimer's disease	0.00206	0.0175	CcSEcCtD
Fludrocortisone—Hirsutism—Donepezil—Alzheimer's disease	0.00205	0.0174	CcSEcCtD
Fludrocortisone—Multiple fractures—Donepezil—Alzheimer's disease	0.00205	0.0174	CcSEcCtD
Fludrocortisone—Fracture—Donepezil—Alzheimer's disease	0.00205	0.0174	CcSEcCtD
Fludrocortisone—Osteoporosis—Memantine—Alzheimer's disease	0.00193	0.0164	CcSEcCtD
Fludrocortisone—Osteoporosis—Rivastigmine—Alzheimer's disease	0.00189	0.016	CcSEcCtD
Fludrocortisone—Multiple fractures—Memantine—Alzheimer's disease	0.00186	0.0158	CcSEcCtD
Fludrocortisone—Fracture—Memantine—Alzheimer's disease	0.00186	0.0158	CcSEcCtD
Fludrocortisone—Fracture—Rivastigmine—Alzheimer's disease	0.00182	0.0154	CcSEcCtD
Fludrocortisone—Multiple fractures—Rivastigmine—Alzheimer's disease	0.00182	0.0154	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—Alzheimer's disease	0.00181	0.0573	CbGpPWpGaD
Fludrocortisone—Cataract—Galantamine—Alzheimer's disease	0.00162	0.0137	CcSEcCtD
Fludrocortisone—Peptic ulcer—Rivastigmine—Alzheimer's disease	0.00158	0.0134	CcSEcCtD
Fludrocortisone—Glaucoma—Donepezil—Alzheimer's disease	0.00158	0.0134	CcSEcCtD
Fludrocortisone—Glycosuria—Donepezil—Alzheimer's disease	0.00147	0.0125	CcSEcCtD
Fludrocortisone—Glaucoma—Memantine—Alzheimer's disease	0.00144	0.0122	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00143	0.0121	CcSEcCtD
Fludrocortisone—Glaucoma—Rivastigmine—Alzheimer's disease	0.00141	0.0119	CcSEcCtD
Fludrocortisone—Contusion—Donepezil—Alzheimer's disease	0.00137	0.0116	CcSEcCtD
Fludrocortisone—Cataract—Donepezil—Alzheimer's disease	0.00125	0.0106	CcSEcCtD
Fludrocortisone—Vascular purpura—Galantamine—Alzheimer's disease	0.00125	0.0106	CcSEcCtD
Fludrocortisone—Injury—Galantamine—Alzheimer's disease	0.00122	0.0103	CcSEcCtD
Fludrocortisone—Purpura—Galantamine—Alzheimer's disease	0.00116	0.00982	CcSEcCtD
Fludrocortisone—Cataract—Memantine—Alzheimer's disease	0.00114	0.00964	CcSEcCtD
Fludrocortisone—Cataract—Rivastigmine—Alzheimer's disease	0.00111	0.00943	CcSEcCtD
Fludrocortisone—Oesophagitis—Donepezil—Alzheimer's disease	0.00109	0.00923	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR6—Alzheimer's disease	0.00109	0.0344	CbGpPWpGaD
Fludrocortisone—Ecchymosis—Donepezil—Alzheimer's disease	0.00108	0.00914	CcSEcCtD
Fludrocortisone—AR—Notch-mediated HES/HEY network—RCAN1—Alzheimer's disease	0.00104	0.0329	CbGpPWpGaD
Fludrocortisone—Fluid retention—Rivastigmine—Alzheimer's disease	0.00101	0.00852	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Donepezil—Alzheimer's disease	0.000995	0.00843	CcSEcCtD
Fludrocortisone—Oesophagitis—Memantine—Alzheimer's disease	0.000989	0.00838	CcSEcCtD
Fludrocortisone—Muscular weakness—Galantamine—Alzheimer's disease	0.000985	0.00835	CcSEcCtD
Fludrocortisone—Neoplasm—Memantine—Alzheimer's disease	0.000979	0.0083	CcSEcCtD
Fludrocortisone—Oesophagitis—Rivastigmine—Alzheimer's disease	0.000968	0.0082	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.000963	0.00816	CcSEcCtD
Fludrocortisone—Neoplasm—Rivastigmine—Alzheimer's disease	0.000958	0.00812	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.000955	0.00809	CcSEcCtD
Fludrocortisone—Injury—Donepezil—Alzheimer's disease	0.000942	0.00798	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Memantine—Alzheimer's disease	0.000908	0.00769	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Memantine—Alzheimer's disease	0.000904	0.00766	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.000888	0.00753	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.000884	0.00749	CcSEcCtD
Fludrocortisone—Vascular purpura—Memantine—Alzheimer's disease	0.000879	0.00745	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000871	0.00738	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Memantine—Alzheimer's disease	0.000867	0.00734	CcSEcCtD
Fludrocortisone—Vascular purpura—Rivastigmine—Alzheimer's disease	0.00086	0.00728	CcSEcCtD
Fludrocortisone—Injury—Memantine—Alzheimer's disease	0.000855	0.00725	CcSEcCtD
Fludrocortisone—Affect lability—Donepezil—Alzheimer's disease	0.000852	0.00722	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—NOS3—Alzheimer's disease	0.000842	0.0267	CbGpPWpGaD
Fludrocortisone—Injury—Rivastigmine—Alzheimer's disease	0.000837	0.00709	CcSEcCtD
Fludrocortisone—Mood swings—Donepezil—Alzheimer's disease	0.00082	0.00695	CcSEcCtD
Fludrocortisone—Purpura—Memantine—Alzheimer's disease	0.000816	0.00691	CcSEcCtD
Fludrocortisone—Purpura—Rivastigmine—Alzheimer's disease	0.000798	0.00676	CcSEcCtD
Fludrocortisone—Haemoglobin—Galantamine—Alzheimer's disease	0.000777	0.00658	CcSEcCtD
Fludrocortisone—Affect lability—Memantine—Alzheimer's disease	0.000774	0.00656	CcSEcCtD
Fludrocortisone—Haemorrhage—Galantamine—Alzheimer's disease	0.000773	0.00655	CcSEcCtD
Fludrocortisone—Muscular weakness—Donepezil—Alzheimer's disease	0.000764	0.00647	CcSEcCtD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00076	0.0241	CbGpPWpGaD
Fludrocortisone—Affect lability—Rivastigmine—Alzheimer's disease	0.000757	0.00641	CcSEcCtD
Fludrocortisone—Abdominal distension—Donepezil—Alzheimer's disease	0.000753	0.00638	CcSEcCtD
Fludrocortisone—Mood swings—Memantine—Alzheimer's disease	0.000745	0.00631	CcSEcCtD
Fludrocortisone—Pancreatitis—Donepezil—Alzheimer's disease	0.000734	0.00622	CcSEcCtD
Fludrocortisone—Sweating increased—Donepezil—Alzheimer's disease	0.000729	0.00618	CcSEcCtD
Fludrocortisone—Mood swings—Rivastigmine—Alzheimer's disease	0.000728	0.00617	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—GRN—Alzheimer's disease	0.000711	0.0225	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Memantine—Alzheimer's disease	0.000693	0.00587	CcSEcCtD
Fludrocortisone—NR3C2—forebrain—Alzheimer's disease	0.00068	0.109	CbGeAlD
Fludrocortisone—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000678	0.00575	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000675	0.00572	CcSEcCtD
Fludrocortisone—Pancreatitis—Memantine—Alzheimer's disease	0.000666	0.00564	CcSEcCtD
Fludrocortisone—Sweating increased—Memantine—Alzheimer's disease	0.000662	0.00561	CcSEcCtD
Fludrocortisone—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000652	0.00552	CcSEcCtD
Fludrocortisone—Sweating increased—Rivastigmine—Alzheimer's disease	0.000647	0.00549	CcSEcCtD
Fludrocortisone—NR3C2—telencephalon—Alzheimer's disease	0.000625	0.101	CbGeAlD
Fludrocortisone—Hyperglycaemia—Memantine—Alzheimer's disease	0.000613	0.00519	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—CELF1—Alzheimer's disease	0.000608	0.0192	CbGpPWpGaD
Fludrocortisone—Vertigo—Galantamine—Alzheimer's disease	0.000604	0.00512	CcSEcCtD
Fludrocortisone—Haemoglobin—Donepezil—Alzheimer's disease	0.000602	0.0051	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000599	0.00508	CcSEcCtD
Fludrocortisone—Haemorrhage—Donepezil—Alzheimer's disease	0.000599	0.00508	CcSEcCtD
Fludrocortisone—Convulsion—Galantamine—Alzheimer's disease	0.000583	0.00494	CcSEcCtD
Fludrocortisone—Hypertension—Galantamine—Alzheimer's disease	0.000581	0.00492	CcSEcCtD
Fludrocortisone—Myalgia—Galantamine—Alzheimer's disease	0.000573	0.00485	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—PPP5C—Alzheimer's disease	0.000566	0.0179	CbGpPWpGaD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—Alzheimer's disease	0.000557	0.0176	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Memantine—Alzheimer's disease	0.000547	0.00463	CcSEcCtD
Fludrocortisone—Haemorrhage—Memantine—Alzheimer's disease	0.000544	0.00461	CcSEcCtD
Fludrocortisone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000535	0.00453	CcSEcCtD
Fludrocortisone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000532	0.00451	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000531	0.0045	CcSEcCtD
Fludrocortisone—Erythema—Donepezil—Alzheimer's disease	0.000521	0.00442	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.000506	0.016	CbGpPWpGaD
Fludrocortisone—AR—forebrain—Alzheimer's disease	0.000503	0.0811	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.0005	0.00424	CcSEcCtD
Fludrocortisone—Insomnia—Galantamine—Alzheimer's disease	0.000497	0.00421	CcSEcCtD
Fludrocortisone—Vertigo—Donepezil—Alzheimer's disease	0.000468	0.00397	CcSEcCtD
Fludrocortisone—Erythema—Rivastigmine—Alzheimer's disease	0.000463	0.00392	CcSEcCtD
Fludrocortisone—AR—telencephalon—Alzheimer's disease	0.000463	0.0745	CbGeAlD
Fludrocortisone—Convulsion—Donepezil—Alzheimer's disease	0.000452	0.00383	CcSEcCtD
Fludrocortisone—Hypertension—Donepezil—Alzheimer's disease	0.00045	0.00381	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000446	0.0141	CbGpPWpGaD
Fludrocortisone—Myalgia—Donepezil—Alzheimer's disease	0.000444	0.00376	CcSEcCtD
Fludrocortisone—Oedema—Donepezil—Alzheimer's disease	0.000425	0.00361	CcSEcCtD
Fludrocortisone—Vertigo—Memantine—Alzheimer's disease	0.000425	0.0036	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAQ—Alzheimer's disease	0.000424	0.0134	CbGpPWpGaD
Fludrocortisone—Infection—Donepezil—Alzheimer's disease	0.000423	0.00358	CcSEcCtD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARGC1A—Alzheimer's disease	0.000422	0.0134	CbGpPWpGaD
Fludrocortisone—Vertigo—Rivastigmine—Alzheimer's disease	0.000416	0.00353	CcSEcCtD
Fludrocortisone—NR3C1—embryo—Alzheimer's disease	0.000412	0.0664	CbGeAlD
Fludrocortisone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000411	0.00349	CcSEcCtD
Fludrocortisone—Convulsion—Memantine—Alzheimer's disease	0.00041	0.00348	CcSEcCtD
Fludrocortisone—Hypertension—Memantine—Alzheimer's disease	0.000409	0.00346	CcSEcCtD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000407	0.0129	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Galantamine—Alzheimer's disease	0.000404	0.00343	CcSEcCtD
Fludrocortisone—Myalgia—Memantine—Alzheimer's disease	0.000403	0.00342	CcSEcCtD
Fludrocortisone—Convulsion—Rivastigmine—Alzheimer's disease	0.000401	0.0034	CcSEcCtD
Fludrocortisone—Hypertension—Rivastigmine—Alzheimer's disease	0.0004	0.00339	CcSEcCtD
Fludrocortisone—Myalgia—Rivastigmine—Alzheimer's disease	0.000394	0.00334	CcSEcCtD
Fludrocortisone—Asthenia—Galantamine—Alzheimer's disease	0.000394	0.00334	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000388	0.00329	CcSEcCtD
Fludrocortisone—Oedema—Memantine—Alzheimer's disease	0.000386	0.00327	CcSEcCtD
Fludrocortisone—Insomnia—Donepezil—Alzheimer's disease	0.000385	0.00326	CcSEcCtD
Fludrocortisone—Infection—Memantine—Alzheimer's disease	0.000384	0.00325	CcSEcCtD
Fludrocortisone—Oedema—Rivastigmine—Alzheimer's disease	0.000378	0.0032	CcSEcCtD
Fludrocortisone—Infection—Rivastigmine—Alzheimer's disease	0.000375	0.00318	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000373	0.00316	CcSEcCtD
Fludrocortisone—NR3C2—nervous system—Alzheimer's disease	0.000369	0.0594	CbGeAlD
Fludrocortisone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000365	0.0031	CcSEcCtD
Fludrocortisone—NR3C1—forebrain—Alzheimer's disease	0.000365	0.0587	CbGeAlD
Fludrocortisone—NR3C2—central nervous system—Alzheimer's disease	0.000355	0.0572	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000352	0.00298	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.00035	0.0111	CbGpPWpGaD
Fludrocortisone—Insomnia—Memantine—Alzheimer's disease	0.000349	0.00296	CcSEcCtD
Fludrocortisone—NR3C2—cerebellum—Alzheimer's disease	0.000347	0.0559	CbGeAlD
Fludrocortisone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000344	0.00292	CcSEcCtD
Fludrocortisone—Headache—Galantamine—Alzheimer's disease	0.000344	0.00291	CcSEcCtD
Fludrocortisone—Insomnia—Rivastigmine—Alzheimer's disease	0.000342	0.0029	CcSEcCtD
Fludrocortisone—Urticaria—Donepezil—Alzheimer's disease	0.000338	0.00286	CcSEcCtD
Fludrocortisone—NR3C1—telencephalon—Alzheimer's disease	0.000335	0.054	CbGeAlD
Fludrocortisone—AR—FOXA1 transcription factor network—SOD1—Alzheimer's disease	0.00033	0.0105	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—PTK2B—Alzheimer's disease	0.000329	0.0104	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.000322	0.0102	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000313	0.00266	CcSEcCtD
Fludrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.000311	0.00985	CbGpPWpGaD
Fludrocortisone—Urticaria—Memantine—Alzheimer's disease	0.000307	0.0026	CcSEcCtD
Fludrocortisone—Asthenia—Donepezil—Alzheimer's disease	0.000305	0.00259	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000301	0.00955	CbGpPWpGaD
Fludrocortisone—Urticaria—Rivastigmine—Alzheimer's disease	0.0003	0.00254	CcSEcCtD
Fludrocortisone—Hypersensitivity—Memantine—Alzheimer's disease	0.000285	0.00241	CcSEcCtD
Fludrocortisone—NR3C2—brain—Alzheimer's disease	0.000282	0.0454	CbGeAlD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.00028	0.00888	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000278	0.00236	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.000278	0.00881	CbGpPWpGaD
Fludrocortisone—Asthenia—Memantine—Alzheimer's disease	0.000277	0.00235	CcSEcCtD
Fludrocortisone—AR—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.000277	0.00878	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.000277	0.00876	CbGpPWpGaD
Fludrocortisone—AR—nervous system—Alzheimer's disease	0.000273	0.044	CbGeAlD
Fludrocortisone—Asthenia—Rivastigmine—Alzheimer's disease	0.000271	0.0023	CcSEcCtD
Fludrocortisone—Headache—Donepezil—Alzheimer's disease	0.000267	0.00226	CcSEcCtD
Fludrocortisone—AR—central nervous system—Alzheimer's disease	0.000263	0.0424	CbGeAlD
Fludrocortisone—AR—Nuclear Receptors—ESR1—Alzheimer's disease	0.000262	0.00829	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000256	0.00812	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000256	0.00812	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000248	0.00786	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.000246	0.00779	CbGpPWpGaD
Fludrocortisone—Headache—Memantine—Alzheimer's disease	0.000242	0.00205	CcSEcCtD
Fludrocortisone—AR—Nuclear Receptors—PPARG—Alzheimer's disease	0.000239	0.00756	CbGpPWpGaD
Fludrocortisone—Headache—Rivastigmine—Alzheimer's disease	0.000237	0.00201	CcSEcCtD
Fludrocortisone—AR—FOXA1 transcription factor network—ESR1—Alzheimer's disease	0.000233	0.00737	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000229	0.00724	CbGpPWpGaD
Fludrocortisone—Triamcinolone—BCHE—Alzheimer's disease	0.000225	0.177	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000218	0.0069	CbGpPWpGaD
Fludrocortisone—Fluoxymesterone—ESR1—Alzheimer's disease	0.000218	0.172	CrCbGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.000217	0.00687	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—NOTCH1—Alzheimer's disease	0.000213	0.00676	CbGpPWpGaD
Fludrocortisone—AR—brain—Alzheimer's disease	0.000209	0.0336	CbGeAlD
Fludrocortisone—AR—FOXA1 transcription factor network—INS—Alzheimer's disease	0.000208	0.00659	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000207	0.00655	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000205	0.00649	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.000203	0.00642	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000201	0.00637	CbGpPWpGaD
Fludrocortisone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.000199	0.00629	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.000199	0.00629	CbGpPWpGaD
Fludrocortisone—NR3C1—nervous system—Alzheimer's disease	0.000198	0.0319	CbGeAlD
Fludrocortisone—NR3C2—Gene Expression—PHF1—Alzheimer's disease	0.000196	0.00619	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000194	0.00616	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000194	0.00616	CbGpPWpGaD
Fludrocortisone—NR3C1—central nervous system—Alzheimer's disease	0.000191	0.0307	CbGeAlD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000189	0.00597	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000188	0.00596	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.000188	0.00596	CbGpPWpGaD
Fludrocortisone—Medroxyprogesterone Acetate—ESR1—Alzheimer's disease	0.000187	0.147	CrCbGaD
Fludrocortisone—NR3C1—cerebellum—Alzheimer's disease	0.000186	0.03	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000184	0.00582	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.000183	0.00579	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000182	0.00576	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.000181	0.00574	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000177	0.0056	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000174	0.00552	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000174	0.00552	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NOS2—Alzheimer's disease	0.000172	0.135	CrCbGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000167	0.00529	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000165	0.00524	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000165	0.00523	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000161	0.00511	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000159	0.00503	CbGpPWpGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.000158	0.005	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000157	0.00497	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000156	0.00495	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000155	0.00492	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000155	0.00492	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000154	0.00487	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000153	0.00483	CbGpPWpGaD
Fludrocortisone—NR3C1—brain—Alzheimer's disease	0.000151	0.0244	CbGeAlD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000151	0.00478	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000151	0.00478	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.000149	0.00472	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000146	0.00463	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000144	0.00455	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000143	0.00453	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000143	0.00452	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00014	0.00442	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000138	0.00437	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.000137	0.00435	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000134	0.00425	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.000133	0.00422	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.000133	0.00421	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000129	0.0041	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000129	0.00407	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000127	0.00403	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000127	0.00401	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TFAM—Alzheimer's disease	0.000126	0.00399	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000125	0.00397	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000125	0.00396	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000123	0.00389	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000122	0.00386	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.00012	0.00382	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.00012	0.00381	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.00012	0.0038	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.000119	0.00377	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000118	0.00373	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000116	0.00367	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000115	0.00363	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000115	0.00363	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000113	0.00357	CbGpPWpGaD
Fludrocortisone—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.000111	0.00352	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.00011	0.00347	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000108	0.00343	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000108	0.00343	CbGpPWpGaD
Fludrocortisone—Progesterone—ESR1—Alzheimer's disease	0.000108	0.085	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000108	0.00341	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000107	0.0034	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000105	0.00332	CbGpPWpGaD
Fludrocortisone—Triamcinolone—PTGS2—Alzheimer's disease	0.000103	0.0815	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.000102	0.00323	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.0001	0.00317	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	9.75e-05	0.00309	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	9.73e-05	0.00308	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	9.66e-05	0.00306	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	9.59e-05	0.00304	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	9.53e-05	0.00302	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	9.32e-05	0.00295	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LPL—Alzheimer's disease	9.27e-05	0.00294	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	9.19e-05	0.00291	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PHF1—Alzheimer's disease	9.08e-05	0.00287	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	8.92e-05	0.00282	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	8.8e-05	0.00279	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	8.68e-05	0.00275	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	8.55e-05	0.00271	CbGpPWpGaD
Fludrocortisone—Betamethasone—PTGS2—Alzheimer's disease	8.47e-05	0.0668	CrCbGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	8.21e-05	0.0026	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	7.94e-05	0.00252	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	7.81e-05	0.00247	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—Alzheimer's disease	7.77e-05	0.00246	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—ESR1—Alzheimer's disease	7.7e-05	0.00244	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	7.61e-05	0.00241	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	7.59e-05	0.0024	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—EIF2S1—Alzheimer's disease	7.59e-05	0.0024	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	7.44e-05	0.00236	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	7.23e-05	0.00229	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	7.19e-05	0.00228	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—Alzheimer's disease	7.02e-05	0.00222	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PHF1—Alzheimer's disease	6.89e-05	0.00218	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	6.77e-05	0.00214	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	6.68e-05	0.00211	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—INS—Alzheimer's disease	6.64e-05	0.0021	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	6.57e-05	0.00208	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	6.56e-05	0.00208	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	6.47e-05	0.00205	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	6.47e-05	0.00205	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	6.46e-05	0.00205	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	6.42e-05	0.00203	CbGpPWpGaD
Fludrocortisone—Progesterone—CYP2D6—Alzheimer's disease	6.42e-05	0.0506	CrCbGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	6.37e-05	0.00202	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	6.32e-05	0.002	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	6.22e-05	0.00197	CbGpPWpGaD
Fludrocortisone—Dexamethasone—CYP2D6—Alzheimer's disease	5.87e-05	0.0463	CrCbGaD
Fludrocortisone—AR—Gene Expression—TFAM—Alzheimer's disease	5.85e-05	0.00185	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	5.78e-05	0.00183	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	5.77e-05	0.00183	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	5.65e-05	0.00179	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	5.63e-05	0.00178	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	5.43e-05	0.00172	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	5.2e-05	0.00165	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	5.16e-05	0.00163	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	5.15e-05	0.00163	CbGpPWpGaD
Fludrocortisone—Dexamethasone—PTGS2—Alzheimer's disease	4.93e-05	0.0388	CrCbGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	4.91e-05	0.00155	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	4.79e-05	0.00152	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	4.78e-05	0.00151	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	4.78e-05	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	4.76e-05	0.00151	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	4.58e-05	0.00145	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TFAM—Alzheimer's disease	4.44e-05	0.00141	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	4.4e-05	0.00139	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	4.28e-05	0.00136	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	4.27e-05	0.00135	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	4.2e-05	0.00133	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	4.1e-05	0.0013	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.07e-05	0.00129	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	3.91e-05	0.00124	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	3.87e-05	0.00123	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	3.85e-05	0.00122	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.73e-05	0.00118	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.71e-05	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—ESR1—Alzheimer's disease	3.71e-05	0.00117	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.63e-05	0.00115	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—TNF—Alzheimer's disease	3.6e-05	0.00114	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—NOTCH1—Alzheimer's disease	3.58e-05	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	3.57e-05	0.00113	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—EIF2S1—Alzheimer's disease	3.52e-05	0.00112	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.48e-05	0.0011	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	3.45e-05	0.00109	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—PPARG—Alzheimer's disease	3.38e-05	0.00107	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.31e-05	0.00105	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	3.26e-05	0.00103	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.13e-05	0.000991	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.11e-05	0.000984	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.07e-05	0.000973	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	2.9e-05	0.000919	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	2.71e-05	0.000858	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	2.67e-05	0.000846	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	2.62e-05	0.00083	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.59e-05	0.000821	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.51e-05	0.000794	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	2.47e-05	0.000783	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—ESR1—Alzheimer's disease	1.72e-05	0.000545	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—NOTCH1—Alzheimer's disease	1.66e-05	0.000526	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—Alzheimer's disease	1.57e-05	0.000497	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—AKT1—Alzheimer's disease	1.34e-05	0.000423	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	1.3e-05	0.000413	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	1.26e-05	0.000399	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	1.19e-05	0.000377	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—AKT1—Alzheimer's disease	6.2e-06	0.000196	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	4.71e-06	0.000149	CbGpPWpGaD
